<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 245 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page244.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=245">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 245 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 245</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=245"><img src="../thumb/245.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>208 / 2020-04                                                               Ophthalmics - 15.7
   Side effects: Post-op inflamm.reacts., corn.oed., corn.decomposit.  warn pt.to report sympts.suggest.endophthalmit.& mang. appropr.   incl. clinic. exam./optic.tomography or fluoresc.angiography. Monit.
   Special precautions: Do not use other addit., do not use until re-  pot.risk of arter.thromboembol.events, pot.for immunogenocit., ensure   freq.determ. by treat.med.practit.
   constit., diab.pts.& undergo. vitrect.  contracept.in wom. of childbear.pot. & contin.for 3 mnths aft.treatm.  Admin.und.asept.techniq.as per manufact.instruct. Admin.adeq.an-
   CELLUFRESH, Allergan, [P/S]  FLUORESCITE 10%, Alcon [P/S]  aesthes.& broad spec.topic. microbicide prior to inj. Pt to self-admin.
                                                              antimicrob. drps 4xdly x3 days bef.& aft.inj.
   Carboxymethylcellulose sod.  Fluorescein.                  Contraindications: Safety & effic.beyond 24 mnths. not est.,
   Indications: Lubric.to relieve irrit.& discomf.from dry eyes/wind/sun  Indications: Diagnost.angiography/angioscopy of retina & iris   act./suspect.ocul./periocul. infects., act.sev.intraocul.inflammat.,
   (S0) EYE DROPS. 32/15.4/0477. 5 mg/ml.  vasculature.       pregn.& lactat., safety & effic.admin.to both eyes concurr. not stud-
   861510-003: 30 x 0,4 ml sngl.dos.vials, R105,32  (S3) IV INJ. A40/28/0679. 100 mg/ml.  ied, adjunct.with verteporfin photodynam. ther. in wet AMD/PM,
   Dosage: 1-2 drps.in affect.eye(s) 4xdly as need.  709634-001: 12 x 5 ml, R4 018,28  mix.with other prod., no studies with concurr.eye condits.e.g. retin.
   Side effects: Irrit., trans.blurr., eye pain/-prurit.-discharge, vis.  Dosage: Inject contents into antecubital vein rapid (1 ml/sec.  detachm. /macul.hole.
   disturbs. hypersens., incr.lacriminat., ocul.hyperaem., superfic.eye   recomm). Adults: Norm.dos.500 mg. Childr.: Recomm.dos.7,7 mg/  Side effects: Endophthalmit., intraocul. inflammat., rhegmatogen.
   injur., eye abras.           kg body weight.               retin.detachm., iatrogen. traumat. cataract, nasopharyngit., influenza,
   Warnings and special precautions: Re-assess. condit.in event   See manufact.prod.literat.for admin.instruct.  UTI, anaem., anx., headache, stroke, vitrit., vitreous float./ detachm.,
   of irrit./pain/redn./vis.changes or worsen., avoid.contaminat.& direct   Contraindications: Hypersens.to fluorescein sodium or any other   retin./conjunctiv. haemorrh., vis. disturbs., eye pain/irrit./prurit./disch.,
   eye cont., safety in pregn.&lactat.not est., observ.15 min. interv.betw.  ingred., safety & effic.in pregn. & lactat.not est.  foreign body sens. in eyes, incr.lacrimat., dry eye, blepharit., ocul. hyper-
   other concom.eye med         Side effects: Hypersens.reacts, anaphylact reacts./ shock, uriticar.,   aem., retin.degenerat./disord./ detachm./ tear, retin.pigment epitheli-
   CELLUVISC, Allergan [P/S]    anaphylactoid reacts./ shock, dysgeus., headache, syncope, convuls.,   um detachm./tear, vis.acuity reduc., vitreous haemorrh./ disord., uveit.,
   Carboxymethylcellulose sod.  card.arrest, bradycard., tachycard., thrombophlebit., hypotens., shock,   iritis, iridocyclit., cataract, cataract subcapsul., poster.caps. opacificat.,
   Indications: Irrit.& discomf.relief of dry eyes/ wind or sun expos.  hot flush, hypertens., pallor, bronchosp., asthma, cough, dyspn., la-  punct.keratit., corn.abras., ant. chamber flare, blurr.vis., inj.site/eye
   (S0) DROPS, 30/15.4/0144. 10 mg/ml.  ryngeal/nasal/pulm.oed, resp.arrest, sneez., abdom.discomf., N&V,   haemorrh., conjunctivit., allerg.conjunctivit., photops., photophob.,
   825085-004: 30x0,4 ml sngl.use contain., R127,67  prurit., extravasat., death  ocul.discomf., eyelid irrit./oed./pain, conjunctiv.hyperaem., blindn.,
   Dosage: Apply 1-2 drps.in each eye as reqd.  Special precaution: Avoid extravasat dur.inj., poss.death due   loc.reacts., endophthalmit., hypopyon., hyphaema, keratopathy, iris
   Side effects: Eye irrit./-pain, blurr.vis., incr. lacrimat., ocul.hyperaem.  to anaphylax.report., allerg./ bronch. asthma hist., yellow skin &   adhes., corn.depos./oed./striae, abnorm. sensat.in eyes, cough, naus.,
   Warnings and special precautions: Discont.if irrit./pain/redn.or   urine discol.  skin/allerg. reacts., arthralg., incr.IOP, arter.thromboembol. events.
   vis.changes occur/worsen, remove contact lenses & insert.15 mins   Warning: Not for intrathecal or intra-arterial use.  Warnings and special precautions: Adeq. contracept. in women
   aft.admin., concom.ophthalmic meds.to be admin.15 mins prior to   I-GLO, (Aspen Pharmacare: Consumer) Pharmacare [P/S]  of childbear.potent., potent. teratogen., not recomm.in childr.& ado-
   instillat., safety & effic.dur.pregn.& lactat.not est., discard aft.use,   Phenylephr.HCl 2,5 mg, boric acid 92 mg, borax 27,5 mg NaCl   lesc.due to lack of safety & effic. data, monit.for early detect. & treatm.
   do not store open contain.   34 mg/5 ml.                   of poss. infect., endophthalmit., poss. immunogenicity, arter.thrombot.
   DUOVISC, Alcon [P/S]         Indications: Inflam.sore irrit./red & tired eyes.  event risk., known stroke risk fact.& stroke/TIA hist., limit.exper.with
                                                              prior RVO episod./ischaem.branch RVO (BRVO)& centr. RVO (CRVO),
   Sngl.blist.packs contain.dispos.glass syringes deliver.0,35 ml or 0,5 ml   (S0) DROPS. H1319.  ther.not recomm.in RVO pts. present. with signs of irrevers.ischaem.
   Viscoat and either 0,4 ml or 0,55 ml Provisc.  783625-006: 15 ml, R14,97  vis. funct. loss, omonit.& manage IOP & perfus.of optic nerve head,
   Indications: Prov.of two viscoelastic mat.with diff.physicochemic.  Dosage: 1-2 drps.morn.& even.  vis.disturbs.may affect driv./mach.operat. abil.
   propert.used to perform spec. tasks dur.cataract proced.  Contraindications: Narr.angle glauc.  See also MDR page 128.
   (S4) VISCOELAST.SYST, 33/3/0182  Side effects: Allerg.reacts.
   882911-004: 1x0,35 ml Viscoat & 1x 0,4 ml Provisc, R1 261,72  Special precautions: Infts., concom guanethidine & other syst.  MINIMS FLUORESCEIN SODIUM 2 %, (Bausch & Lomb)
   882903-001: 1x0,5 ml Viscoat & 1x 0,55 ml Provisc, R1 766,39  adrenerg.block.agents.  SofLens [P/S]
   Special precautions: Allow to attain room temp.prior to use.  Fluorescein sod.
   See respect.manufact.product lit.for further details.  KELOPT, Actor [P/S]  Indications: Detect.corneal abras.& foreign bodies, applanation
                                Ketorolac tromethamine.
   DURATEARS PRESERVATIVE FREE, Alcon [P/S]  Indications: Inflam.relief follow.ocul.surg.  tonometry, assess.patency of nasolacrimal duct,contact lens fitt.
                                                              (S1) SOL, T/15.4/86. 10 mg/0,5 ml
   Anhydr.liq.lanolin.          (S3) OPHTH.SOL., 45/15.4/1033. 5 mg/ml.  743534-026: 20x0,5 ml, R434,85
   Indications: Eye lubric.     723869-001: 5 ml, R160,47     Dosage:. Sngl.dos.eye drops. Apply suffic.sol.to stain damage.area,
   (S0) OINT. J/15.4/290. 30 mg/g.  Dosage: 1 drp.4xdly.commenc.24 hrs.bef.surg.& contin. post-op.   wash away excess with sterile saline sol.
   721719-007: 3,5 g, R84,90    Use beyond 14 days post surg. incr.risk & sev.of corn.advers.events.  Contraindications: Soft contact lenses
   Dosage: Small ribbon in conjunct.sac./into affect area  Contraindications: Aspir./NSAID’s hypersens., safety & effic. in   Side effects: Allerg., anaphylax., allerg. conjunctivit., periorbit.oed.,
   Special precautions: Discont.if persist.ocul.irrit.  childr.not est., pregn.& lactat., soft contact lens in situ.  urticar., rash, angioed.
                                Side effects: Sting., burn., ocul.oed./-inflammat./-irrit./-pain, su-
   EMADINE, Novartis [P/S]      perfic.keratit.& ocul. infects., corn.infiltrat., conjunctiv.hyperaem.,   Special precautions: Avoid microb.contamin.
   Emedastine base              iritis, dry eyes, corn.oed./-ulcerat./-eros./-perforat./-thinn., epithel.  MINIMS LIDOCAINE & FLUORESCEIN, (Bausch & Lomb)
   Indications: Season.allerg.conjunctivit.  breakdown, allerg./loc.reacts., headache.  SofLens [P/S]
   (S2) SOL. 34/15.4/0037. 0,5 mg/ml  Warnings and special precautions: Due to poss. aspir./NSAID’s   Lidocaine HCl 20 mg, fluorescein sod. 1,25 mg /0,5 ml.
   891449-007: 5 ml, R156,09    cross-sensitiv.asthma pts./ precipitat.rhinit/urticar., signs of infect.   Indications:. Diagnost.loc.anaesth.& stain combin.
   Dosage: Adults & childr.over 3 yrs: Instil 1 drp.2xdly into affect.  poss. mask., poss.incr.ocul.tiss.bleed.with ocul.surg., pept.ulcerat.  (S4) SOL, L/15.4/369
   eye(s). Observ.interv.of 10 mins.betw applic.of other ophthal.meds.  hist., bleed.tendenc., meds.prolong. bleed.time, discont.& monit.in   743488-016: 20x0,5 ml, R379,39
   with oints.applied last. Do not allow dropp.tip to touch eyelids/sur-  pres.of corn.epithel. breakd., incr.sight threat.corn.advers.events in   Dosage: Sngl.dos.eye drops. Adults: 1 or more drps.as direct.by
   round.areas to prev.contamin. Remove snap collar to prev.it acci-  complic. ocul.surg./corn.denervat./corn.epithel. defects /diab.mel-  ophthalmol. Childr: At discret.of ophthalmol.
   dent.fall.into the eye.      lit./ocul.surf.dis./rheumat.arthrit. & rep. ocul.surg.within short pe-  Contraindications: Hypersens.to anaesth.of same group
   Contraindications: Safety in pregn.& lactat.not est., not recom.in   riod of time & if used more than 24 hrs.prior to surg/beyond 14 days   Special precautions: Protect anaesth.eye from contamin.(esp.el-
   pts.&gt;65 yrs.& hepat.& ren. impairm.  post surg., slow/delay.heal.poss., HF poss. precipitat. in comprom.  derly in whom anaesth.durat. exceed 30 mins.).
   Side effects: Dry eye, ocul. hyperaem.& prurit., blurr.vis., corn.stain.,   pts., poss.adverse eff.on corn. permeabil.& corn.epithel.with prolong.
   foreign body sensat., sinus headache, dysgeus., eye pain, conjunc-  MINIMS OXYBUPROCAINE HYDROCHLORIDE 0,4 %,
   tiv. hyperaem., corn.infiltrates, lacrimat., asthenop., rash, abnorm.  use., reg. ophthal.exam.requir., prolong.use with extens. ocul. surf.  (Bausch & Lomb) SofLens [P/S]
   dreams, tachycard., ocul.irrit., headache.  dis., determine S/E bef.driv./operat. machin.  Oxybuprocaine HCl.
   Special precautions: Discont.ther.& implem. appropr.managem.  Drug interactions: Incr.post.-op bleed.risk poss. with anticoags./  Indications: Applanation tonometry, contact lens fitt.
   in event of corn.infiltrates, poss.adverse eff.on corn.permeabil.&   coumarin/indandione deriv./ hepar. & platelet aggregat.inhibit., con-  (S4) SOL. C/15.4/44. 2 mg/0,5 ml
   corn. epithel.with prolong.use.req.reg.opthalm. examinat., prolong.  com. steroids incr.heal.probl.potent.  743526-015: 20x0,5 ml, R329,59
   use with extens.ocul.surf.dis., allow 10 min.interv.bef.insert.contact   LUCENTIS, Novartis [P/S] &  Dosage: Sngl.dos.eye drops. Adults & childr: 1-3 drps.as direct.
   lenses, do not drive/operat.machin.unless vis.clear.  Ranibizumab  by ophthalmol.depend.on degree of anaesth.reqd. Onset: 6-20
   EYLEA, Bayer [P/S]           Indications: Neovasc. (wet)age-relat.macul. degenerat.(AMD), vis.  secs. Durat: 15 mins.
   Aflibercept                  impairm.due to diabet.macul. oed.(DME) & retin.vein occlus.(branch   Contraindications: Allergies, card.dis., hyperthyroid, open lesions.
   Indications: Neovascul. (wet) age-relat. macul. degenerat. (AMD),   RVO/centr. RVO), vis.impairm. due to choroid. neovascularisat. (CNV)  Side effects: Eye allergy, allerg.blepharit., hypersensitiv., anaphylax.,
   macul.oed. follow. centr.retin. vein occlus. (CRVO)  second.to patholog.myop.(PM)  Syst.toxic.( CV-collapse, convuls., hyperexcitab.)
   (S4) SOL.FOR INJ., A46/15.4/0841. 40 mg/ml.  (S4) SOL.FOR INJ, 41/15.4/0860. 10 mg/ml  MINIMS PROXYMETACAINE HYDROCHLORIDE 0,5 %,
   722548-001: 1 vial (100 microlitres equiv to 4 mg), R7 773,54  711524-001: 1 vial with filter needles, 2,3 mg in 0,23 ml of which   (Bausch & Lomb) SofLens [P/S]
   Dosage: Only to be admin.by dr.experienc.in admin. of intravitr.inj.,   0,05 ml (equals 0,5 mg) is inject., R7 773,54  Proxymetacaine HCI
   monit.pt immed.follow. admin. for elev.IOP.  Dosage: Intravitreal inj.only by exper. ophthalmologist. Recomm.  Indications: Topic.ocul.anaesth.
   Neovascul. age-relat.macul.degenerat: 2 mg by intravitr. inj eve-  dos: 0,5 mg (0,05 ml) as sngl.intravitr.inj.  (S4) SOL, 35/15.4/0088. 0,0025 g/0,5 ml
   ry mnth for 3 mnths then every 2 mnths., treatm.interv.may be extend.  Wet age-relat.macul.degenerat./vis.impairm. due to DME:   704504-002: 20x0,5 ml, R321,79
   to every 2-3 mnths. aft.12 mnths based on vis.& anatom. outcom.  Treatm.giv. once mnthly & contin. until vis.acuit. stable for 3 consec.  Dosage: Sngl.dos.eye drops. Adults & childr:
   Macul.oed.follow.centr.retin.vein occlus.: 2 mg by intravitr.  mnthly. assessm. Monit.vis.acuity mnthly.theraft. Resum. mnthly. inj.  Deep anaesth: 1 drp every 5-10 mins.x5-7 applic.
   inj every mnth until vis & anatom. outcom. stable (3 or more con-  when monitor.indicat.loss of vis.acuit & contin.until.vis.acuit.stable   Remov.of sutures: 1-2 drps.2-3 mins.bef.remov. of stitch.
   sec.mnthly. injects. may be req.), treatm.should be contin.& interv.   for 3 consec. mnthly. assessm.  Remov.foreign bodies: 1-2 drps.prior operat.
   may be extend.based on vis.& anatom.outcom. Interv. betw.dos.   Laser photocoagulat.in DME: Admin.concomit. with laser pho-  Tonometry: 1-2 drps.immed bef.measurem.
   should not be &lt; 1 mnth.      tocoagulat./in pts.with prev.laser photocoagulat. When giv.on same   Contraindications: Premat.babies, ocul. inflammat. /infect.
   Contraindications: Ocul./periocul.infect., act. sev. intraocul. in-  day, admin.at least 30 min.aft. photocoagulat.  Side effects: Pupill.dilat./cyclopleg.effs., conjunct. irrit., hyperal-
   flammat., pregn.& lactat.    Vis.impairm.due to macul.oed.second.to RVO: Treatm.giv.mnthly   lerg.corn.react.incl.ac. intense. & diffuse epithel.keratit., allerg.
   Side effects: Conjuntiv. haemorrh., eye pain, retin.pigm.epithel.tear,   & contin.unt. max.vis.acuity achiev .& confirm.by stable vis.acuit.for   contact dermatit.
   detachm.of retin.pigm. epithel., cortic/nucl./subcapsul./traumat.cata-  3 consec. mnthly. assessm. Monit.visual acuity mnthly. theraft. Re-  Special precautions: Known allerg., card.dis., hyperthyroid., do
   ract, corn.eros./abras./oed., IOP, blurr.vis., vitr.floaters/ detachm., inj.  sum.mnthly.inj.when monitor.indicat. loss of vis.acuit & contin.unt.  not rub./touch eye while anaesth. persist, protect eye from dust
   site pain/haemorrh., foreign body sensat.in eye, incr.lacrimat., eyelid   vis.acuity stable for 3 consec. mnthly.assessm.  & bact.contamin.
   oed., punct. keratit., conjuntiv./ocul.hyperaem., endophthalmit., retin.  Laser photocoagulat.in branch RVO: Admin. concomit.with la-
   detachm./tear, uveit, irit., iridocyclit., lenticul. opacit., corn.epithel.  ser photocoagulat./in pts.with prev.laser photocoagulat. When giv.  MINIMS TETRACAINE HCL 1 %, (Bausch & Lomb) SofLens [P/S]
   defect,anter.chamb.flare, vitrit., hypopyon.  on same day, admin.at least 30 min.aft photocoagulat.  Tetracaine HCl
   Warnings and special precautions: Pts.with poorly contr.glauc.,   Vis.impairm.due to CNV second.to PM: Init. ther.with sngl.inj.   Indications: Loc.anaesth.for ophthalm.proced.& min.surg., goni-
   elev.in IOP may occur; monit. perfus. of the optic nerve head & IOP.,   Furth.treatm.recomm. if monit. indic. signs of dis.activ. Monit. may   oscopy in suspect.glauc.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page244.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page240.html">240</a>&nbsp;&nbsp;&nbsp;<a href="page241.html">241</a>&nbsp;&nbsp;&nbsp;<a href="page242.html">242</a>&nbsp;&nbsp;&nbsp;<a href="page243.html">243</a>&nbsp;&nbsp;&nbsp;<a href="page244.html">244</a>&nbsp;&nbsp;&nbsp;<a href="page245.html">245</a>&nbsp;&nbsp;&nbsp;<a href="page246.html">246</a>&nbsp;&nbsp;&nbsp;<a href="page247.html">247</a>&nbsp;&nbsp;&nbsp;<a href="page248.html">248</a>&nbsp;&nbsp;&nbsp;<a href="page249.html">249</a>&nbsp;&nbsp;&nbsp;<a href="page250.html">250</a>
             </td>
             <td width="35%"><a href="page246.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page246.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
